Bibliography
Onoue, S., Matsumoto, A., Nagano, Y., Ohshima, K., Ohmori, Y., Yamada, S., Kimura, R., Yajima, T., & Kashimoto, K. (2004). α-Helical structure in the C-terminus of vasoactive intestinal peptide: functional and structural consequences. European Journal of Pharmacology, 485(1â3), 307â316.
References
53
Referenced
25
10.1093/protein/6.4.383
/ Protein Eng. / Evaluation of secondary structure of proteins from UV circular dichroism spectra using an unsupervised learning neural network by Andrade (1993)10.1021/bi9601520
/ Biochemistry / NMR spectroscopic evidence that helodermin, unlike other members of the secretin/VIP family of peptides, is substantially structured in water by Blankenfeldt (1996)10.1016/0196-9781(86)90162-2
/ Peptides / Conformation of peptides of the secretin-VIP-glucagon family in solution by Bodanszky (1986)10.1016/0045-2068(74)90037-6
/ Bioorg. Chem. / A preferred conformation in the vasoactive intestinal peptide (VIP). Molecular architecture of gastrointestinal hormones by Bodanszky (1974)10.1016/S0022-2836(83)80143-0
/ J. Mol. Biol. / Conformation of glucagon in a lipid–water interphase by 1H nuclear magnetic resonance by Braun (1983)10.1073/pnas.79.24.7909
/ Proc. Natl. Acad. Sci. U. S. A. / Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro by Brazeau (1982){'key': '10.1016/j.ejphar.2003.11.046_BIB7', 'first-page': 'L42', 'article-title': 'Expression, pharmacological, and functional evidence for PACAP/VIP receptors in human lung', 'volume': '277', 'author': 'Busto', 'year': '1999', 'journal-title': 'Am. J. Physiol.'}
/ Am. J. Physiol. / Expression, pharmacological, and functional evidence for PACAP/VIP receptors in human lung by Busto (1999)10.1021/bi00772a015
/ Biochemistry / Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion by Chen (1972)10.1016/0022-2836(86)90147-6
/ J. Mol. Biol. / Solution structure of human growth hormone releasing factor. Combined use of circular dichroism and nuclear magnetic resonance spectroscopy by Clore (1986)10.4049/jimmunol.162.8.4685
/ J. Immunol. / Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation by Delgado (1999)10.1111/j.1749-6632.1988.tb26972.x
/ Ann. N.Y. Acad. Sci. / Conformational analysis of vasoactive intestinal peptide and related fragments by Fournier (1988)10.1016/0196-9781(96)00107-6
/ Peptides / The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors by Gourlet (1996)10.1021/bi00838a031
/ Biochemistry / Computed circular dichroism spectra for the evaluation of protein conformation by Greenfield (1969)10.1016/0014-5793(87)80119-9
/ FEBS Lett. / A 1H-NMR study of the solution conformation of secretin. Resonance assignment and secondary structure by Gronenborn (1987){'key': '10.1016/j.ejphar.2003.11.046_BIB15', 'first-page': '327', 'article-title': 'Solution structure of vasoactive intestinal polypeptide (11–28)-NH2, a fragment with analgesic properties', 'volume': '9', 'author': 'Haghjoo', 'year': '1996', 'journal-title': 'Pept. Res.'}
/ Pept. Res. / Solution structure of vasoactive intestinal polypeptide (11–28)-NH2, a fragment with analgesic properties by Haghjoo (1996)10.1016/0014-5793(84)80607-9
/ FEBS Lett. / Primary structure of helodermin, a VIP-secretin-like peptide isolated from Gila monster venom by Hoshino (1984)10.1111/j.1749-6632.1996.tb17472.x
/ Ann. N.Y. Acad. Sci. / PACAP/VIP receptors in pancreatic beta-cells: their roles in insulin secretion by Inagaki (1996)10.1016/S0016-5085(19)34064-8
/ Gastroenterology / The isolation and chemistry of secretin and cholecystokinin by Jorpes (1968){'key': '10.1016/j.ejphar.2003.11.046_BIB19', 'first-page': '239', 'article-title': 'Synthesis and structure–activity relationships of PACAP', 'volume': '1990', 'author': 'Kitada', 'year': '1991', 'journal-title': 'Pept. Chem.'}
/ Pept. Chem. / Synthesis and structure–activity relationships of PACAP by Kitada (1991)10.1021/bi0004549
/ Biochemistry / Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor by Kobayashi (2000)10.1210/endo-114-5-1506
/ Endocrinology / Characterization and localization of vasoactive intestinal peptide receptors in the rat lung by Leroux (1984){'key': '10.1016/j.ejphar.2003.11.046_BIB22', 'first-page': '61', 'article-title': 'Helodermin analogues: structure–function studies of helodermin', 'volume': '14', 'author': 'Li', 'year': '1993', 'journal-title': 'Biomed. Res.'}
/ Biomed. Res. / Helodermin analogues: structure–function studies of helodermin by Li (1993)10.1073/pnas.93.10.4554
/ Proc. Natl. Acad. Sci. U. S. A. / Structure and function in rhodopsin: correct folding and misfolding in two point mutants in the intradiscal domain of rhodopsin identified in retinitis pigmentosa by Liu (1996)10.1002/9780470122778.ch6
/ Advan. Enzymol. Relat. Areas Mol. Biol. / Solid-phase peptide synthesis by Merrifield (1969)10.1016/S0925-4439(98)00023-4
/ Biochim. Biophys. Acta / Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana by Minn (1998)10.1016/0006-291X(89)91757-9
/ Biochem. Biophys. Res. Commun. / Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells by Miyata (1989)10.1016/0006-291X(90)92140-U
/ Biochem. Biophys. Res. Commun. / Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38) by Miyata (1990){'key': '10.1016/j.ejphar.2003.11.046_BIB28', 'first-page': '1289', 'article-title': 'Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part II: Effect on in vitro and in vivo models of pulmonary anaphylaxis', 'volume': '270', 'author': "O'Donnell", 'year': '1994', 'journal-title': 'J. Pharmacol. Exp. Ther.'}
/ J. Pharmacol. Exp. Ther. / Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part II: Effect on in vitro and in vivo models of pulmonary anaphylaxis by O'Donnell (1994)10.2220/biomedres.20.219
/ Biomed. Res. / Receptor-binding specificity depending on N-terminal structure of VIP/PACAP by Onoue (1999)10.1016/S0196-9781(01)00411-9
/ Peptides / The neuromodulatory effects of VIP/PACAP on PC-12 cells are associated with their N-terminal structures by Onoue (2001)10.1080/10604450214701
/ Pharmacol. Rev. Commun. / Differences in biological activity between PACAP27 and VIP in PC12 cells depend on their N-terminal structure by Onoue (2002)10.1016/S0014-5793(98)01238-1
/ FEBS Lett. / Parasin I, an antimicrobial peptide derived from histone H2A in the catfish, Parasilurus asotus by Park (1998)10.1073/pnas.150518097
/ Proc. Natl. Acad. Sci. U. S. A. / Structure–activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II by Park (2000)10.1016/S0167-0115(97)01031-8
/ Regul. Pept. / PACAP and VIP inhibit pyloric muscle through VIP/PACAP-preferring receptors by Parkman (1997){'key': '10.1016/j.ejphar.2003.11.046_BIB35', 'first-page': '4', 'article-title': 'Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland', 'volume': '17', 'author': 'Rawlings', 'year': '1996', 'journal-title': 'Endocr. Rev.'}
/ Endocr. Rev. / Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland by Rawlings (1996){'key': '10.1016/j.ejphar.2003.11.046_BIB36', 'first-page': '3105', 'article-title': 'Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin', 'volume': '60', 'author': 'Reubi', 'year': '2000', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin by Reubi (2000)10.1038/300276a0
/ Nature / Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour by Rivier (1982)10.1016/S0014-2999(98)00662-1
/ Eur. J. Pharmacol. / Influence of selective VIP receptor agonists in the rat gastric fundus by Robberecht (1998)10.1002/bip.360210615
/ Biopolymers / Lipid-induced conformational changes in glucagon, secretin, and vasoactive intestinal peptide by Robinson (1982)10.1056/NEJM198905113201909
/ N. Engl. J. Med. / Vasoactive intestinal polypeptide and asthma by Said (1989)10.1111/j.1749-6632.1991.tb37985.x
/ Ann. N.Y. Acad. Sci. / Vasoactive intestinal polypeptide (VIP) in asthma by Said (1991)10.1126/science.169.3951.1217
/ Science / Polypeptide with broad biological activity: isolation from the small intestine by Said (1970)10.1006/abio.2000.4880
/ Anal. Biochem. / Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set by Sreerama (2000)10.1016/0165-5728(93)90059-8
/ J. Neuroimmunol. / Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex by Sun (1993)10.1093/protein/12.5.395
/ Protein Eng. / Molecular modeling of single polypeptide chain of calcium-binding protein p26olf from dimeric S100B(betabeta) by Tanaka (1999)10.1002/bip.360310411
/ Biopolymers / Structural determination of the vasoactive intestinal peptide by two-dimensional H-NMR spectroscopy by Theriault (1991)10.1016/0196-9781(86)90105-1
/ Peptides / A fragment of vasoactive intestinal peptide, VIP(10–28), is an antagonist of VIP in the colon carcinoma cell line, HT29 by Turner (1986)10.1146/annurev.ph.40.030178.001515
/ Annu. Rev. Physiol. / Insulin, glucagon, and somatostatin secretion in the regulation of metabolism by Unger (1978)10.1111/j.1432-1033.1992.tb17252.x
/ Eur. J. Biochem. / Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes by Vandermeers (1992){'key': '10.1016/j.ejphar.2003.11.046_BIB50', 'first-page': '269', 'article-title': 'Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions', 'volume': '52', 'author': 'Vaudry', 'year': '2000', 'journal-title': 'Pharmacol. Rev.'}
/ Pharmacol. Rev. / Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions by Vaudry (2000)10.1021/bi00073a016
/ Biochemistry / Solution structure of pituitary adenylate cyclase activating polypeptide by nuclear magnetic resonance spectroscopy by Wray (1993)10.1111/j.1749-6632.1998.tb11160.x
/ Ann. N.Y. Acad. Sci. / Solution structure comparison of the VIP/PACAP family of peptides by NMR spectroscopy by Wray (1998)10.1016/S0196-9781(97)00457-9
/ Peptides / A novel long-acting VIP analog in the guinea pig trachea in vitro by Yoshihara (1998)
Dates
Type | When |
---|---|
Created | 21 years, 8 months ago (Dec. 19, 2003, 5:57 a.m.) |
Deposited | 1 year, 7 months ago (Jan. 11, 2024, 1:14 p.m.) |
Indexed | 1 year, 2 months ago (June 8, 2024, 10:48 p.m.) |
Issued | 21 years, 6 months ago (Feb. 1, 2004) |
Published | 21 years, 6 months ago (Feb. 1, 2004) |
Published Print | 21 years, 6 months ago (Feb. 1, 2004) |
@article{Onoue_2004, title={α-Helical structure in the C-terminus of vasoactive intestinal peptide: functional and structural consequences}, volume={485}, ISSN={0014-2999}, url={http://dx.doi.org/10.1016/j.ejphar.2003.11.046}, DOI={10.1016/j.ejphar.2003.11.046}, number={1–3}, journal={European Journal of Pharmacology}, publisher={Elsevier BV}, author={Onoue, Satomi and Matsumoto, Asami and Nagano, Yumiko and Ohshima, Keiichi and Ohmori, Yuki and Yamada, Shizuo and Kimura, Ryohei and Yajima, Takehiko and Kashimoto, Kazuhisa}, year={2004}, month=feb, pages={307–316} }